Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between codeine / guaifenesin / phenylephrine and pegvisomant

Results for the following 2 drugs:
codeine/guaifenesin/phenylephrine
pegvisomant

Interactions between your drugs

Moderate

codeine pegvisomant

Applies to: codeine / guaifenesin / phenylephrine and pegvisomant

Codeine may reduce the effects of pegvisomant. In clinical trials, patients on narcotic medications often required higher blood levels of pegvisomant to achieve adequate treatment response. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide